However, neuroimaging is not yet state-of-the-art in detecting IDH mutations in glioma, which is one of the reasons tumour sampling is often still necessary, also because surgical resection/debulking is part of the current mainstay of treatment23. This evidence concerns the gene IDH2 and neoplasm.